Imputing Longitudinal Growth Data in International Pediatric Studies: Does CDC Reference Suffice?




Li Zhingue, Toppari Jorma, Lundgren Markus, Frohnert Brigette I, Achenbach Peter, Veijola Riitta, Anand Vibha; T1DI study group

AMIA Annual Symposium

PublisherAmerican Medical Informatics Association

2021

AMIA ... Annual Symposium proceedings. AMIA Symposium

AMIA Annual Symposium Proceedings 2021

AMIA ... Annual Symposium proceedings. AMIA Symposium

AMIA Annu Symp Proc

AMIA ... Annual Symposium proceedings

2021

754

762

1559-4076

1942-597X

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861671

https://research.utu.fi/converis/portal/detail/Publication/174959224



This study investigates a missing value imputation approach for longitudinal growth data in pediatric studies from multiple countries. We analyzed a combined cohort from five natural history studies of type 1 diabetes (T1D) in the US and EU with longitudinal growth measurements for 23,201 subjects. We developed a multiple imputation methodology using LMS parameters of CDC reference data. We measured imputation errors on both combined and individual cohorts using mean absolute percentage error (MAPE) and normalized root-mean-square error (NRMSE). Our results show low imputation errors using CDC reference. Overall height imputation errors were lower than for weight. The largest MAPE for weight and height among all age groups was 4.8% and 1.7%, respectively. When comparing performance between CDC reference and country-specific growth charts, we found no significant differences for height (CDC vs. German: p =0.993, CDC vs. Swedish: p=0.368) and for weight (CDC vs. Swedish: p=0.513) for all ages.

Last updated on 2024-26-11 at 16:56